Bupivacaine Injection
DrugInjection at end of Open Reduction Internal Fixation
NCT Number: NCT06474949
Subjects may receive an injection at the end of the surgery to fix their broken leg that may reduce their pain and hospital stay
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Phase 4
Subjects will be randomized to bupivicaine or saline injection in the joint at the end of Open Reduction Internal Fixation of the tibial plateau fracture
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion:
Injection at end of Open Reduction Internal Fixation
Injection at end of Open Reduction Internal Fixation
Other names: Placebo
Time frame: From date of hospitalization to end of follow-up at 6 months
Pain at time of visit
Time frame: From date of hospitalization up to one month post surgery
Length of stay for hospitalization
Contact information is provided by the study sponsor or research team.
University of Washington
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06931366
Fractures, Bone, Knee Fractures
Asyut, Egypt
View Trial DetailsNCT05037812
Fractures, Bone, Knee Fractures
Salt Lake City, Utah, United States
View Trial DetailsNCT06639503
Fractures, Bone, Knee Fractures
Chicago, Illinois, United States
View Trial DetailsNCT07251699
Fractures, Bone, Knee Fractures
Giza, Giza Governorate, Egypt
View Trial Details